Bill Commons

PA HB 809

in committee

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.

Pennsylvania · 2025-2026 Regular Session (209th General Assembly) · lower

Quick answers

Did PA HB 809 pass?

Not yet. PA HB 809 is in committee as of 2025-03-05 and has not come to a final vote. Latest recorded action (2025-03-05): Referred to Judiciary

What is PA HB 809 about?

PA HB 809 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.”.

Who sponsors PA HB 809?

James Struzzi is the primary sponsor of PA HB 809, joined by 6 cosponsors.

Introduced
Latest action
2025-03-05 — Referred to Judiciary
Bill type
bill
Last updated

Sponsors

  • James Struzziprimary
  • Lindsay Powellcosponsor
  • Dan Frankelcosponsor
  • G. Roni Greencosponsor
  • Tarik Khancosponsor
  • Steven Malagaricosponsor
  • Benjamin Sanchezcosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-03-05

    Referred to Judiciary

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:13.705233Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=HB 809. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.